Ectopic PDX-1 Expression Directly Reprograms Human Keratinocytes along Pancreatic Insulin-Producing Cells Fate by Mauda-Havakuk, Michal et al.
Ectopic PDX-1 Expression Directly Reprograms Human
Keratinocytes along Pancreatic Insulin-Producing Cells
Fate
Michal Mauda-Havakuk
1,2., Naomi Litichever
1,2., Ellad Chernichovski
1,2, Odelia Nakar
1,2, Eyal Winkler
3,
Ram Mazkereth
4, Arie Orenstein
3, Eran Bar-Meir
3, Philippe Ravassard
5, Irit Meivar-Levy
1, Sarah
Ferber
1,2*
1Sheba Regenerative Medicine, Stem Cells and Tissue Engineering Center, Sheba Medical Center, Tel-Hashomer, Israel, 2Department of Human Genetics and Molecular
Medicine, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel, 3Department of Plastic and Reconstructive Surgery, Sheba Medical Center, Tel-Hashomer, Israel,
4Albert Katz Department of Neonatology, Sheba Medical Center, Tel-Hashomer, Israel, 5Biotechnology and Biotherapy group Centre de Recherche Institut du Cerveau et
de la Moelle CNRS UMR7225, INSERM UMRS795, Universite ´ Pierre et Marie Curie, Paris, France
Abstract
Background: Cellular differentiation and lineage commitment have previously been considered irreversible processes.
However, recent studies have indicated that differentiated adult cells can be reprogrammed to pluripotency and, in some
cases, directly into alternate committed lineages. However, although pluripotent cells can be induced in numerous somatic
cell sources, it was thought that inducing alternate committed lineages is primarily only possible in cells of developmentally
related tissues. Here, we challenge this view and analyze whether direct adult cell reprogramming to alternate committed
lineages can cross the boundaries of distinct developmental germ layers.
Methodology/Principal Findings: We ectopically expressed non-integrating pancreatic differentiation factors in ectoderm-
derived human keratinocytes to determine whether these factors could directly induce endoderm-derived pancreatic
lineage and b-cell-like function. We found that PDX-1 and to a lesser extent other pancreatic transcription factors, could
rapidly and specifically activate pancreatic lineage and b-cell-like functional characteristics in ectoderm-derived human
keratinocytes. Human keratinocytes transdifferentiated along the b cell lineage produced processed and secreted insulin in
response to elevated glucose concentrations. Using irreversible lineage tracing for KRT-5 promoter activity, we present
supporting evidence that insulin-positive cells induced by ectopic PDX-1 expression are generated in ectoderm derived
keratinocytes.
Conclusions/Significance: These findings constitute the first demonstration of human ectoderm cells to endoderm derived
pancreatic cells transdifferentiation. The study represents a proof of concept which suggests that transcription factors
induced reprogramming is wider and more general developmental process than initially considered. These results
expanded the arsenal of adult cells that can be used as a cell source for generating functional endocrine pancreatic cells.
Directly reprogramming somatic cells into alternate desired tissues has important implications in developing patient-
specific, regenerative medicine approaches.
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Introduction
Adult cells in mammals were considered terminally differenti-
ated. The differentiation of diverse cell types is achieved by specific
transcription factors that reinforce cell-type-specific gene expres-
sion patterns; these patterns are stabilized by epigenetic modifi-
cations that can be transmitted to daughter cells [1]. However, it
was recently established that the fate of adult somatic cells is not
rigidly fixed; in fact, adult somatic cells have a substantial amount
of developmental plasticity [2–4].
The remarkable transformation of adult cells into pluripotency
has been interpreted as a reversion from the mature state into a
primitive developmental state, which, in many aspects, resembles
embryonic stem cells [5,6]. However, the forced expression of
lineage-specific developmental factors in adult cells induced traits
of various committed cell types without first inducing pluripotency
[7–10] The first example of functional adult cell reprogramming
to the pancreatic lineage in vivo, was documented over a decade
ago [7]. Numerous research groups have been successful in
activating the pancreatic lineage in liver cells from Xenopus laevis
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26298[11], rodents [7,12–17], and humans [18–21], in vivo and in vitro,
respectively. It was suggested that the ectopic expression of a
dominant pancreatic transcription factor, PDX-1, played a critical
role in the reprogramming process [12,19,22–24]. Furthermore,
increased efficiency of the reprogramming process was achieved
by co-expressing PDX-1 with one or several other pancreatic
transcription factors, including MAFA, NGN3, and/or NEU-
ROD1 [16,17,25,26].
The success in activating the endocrine pancreatic lineage in
liver or exocrine pancreas [27,28] has been attributed to the close
developmental relationship between the transconverting tissues;
that is, they all originated from the primitive foregut endoderm
[29–31]. However, the current understanding of stem cell biology
and induced pluripotency favors the notion that every adult tissue
may have the potential to undergo reprogramming to a
pluripotent state in response to defined developmental factors
[32]. The fact that adult cells can be reprogrammed into
pluripotency suggests that cellular integrity is preserved through
adulthood by epigenetic barriers that can be reversed with
developmental stimuli. The general notion that adult cells possess
this plasticity suggests that it may be possible to reprogram adult
somatic cells directly to committed lineages, including the
pancreatic lineage.
This study aimed to determine whether the ability to reprogram
adult cells directly into the endocrine pancreatic lineage and
confer pancreatic function could be applied to a broader spectrum
of cell types than previously suggested. We hypothesized that
reprogramming may be possible between developmentally unre-
lated tissues. To test this, we focused on reprogramming ectoderm-
derived human skin keratinocytes into the endoderm-derived
pancreatic lineage. We chose ectoderm-to-endoderm lineage
reprogramming, because cells from distinct developmental germ
layers have pronounced developmental disparity. We tested
pancreatic transcription factors for the capacity to directly activate
the pancreatic lineage and b-cell-like function without first
inducing pluripotency in human keratinocytes.
Methods
Ethics statement
Human skin tissues were obtained from neonatal foreskins (8
days old) and from split thickness skin grafts (1–4 cm
2), taken from
9–70 years old donors, with approval from the Committee on
Clinical Investigations (institutional review board, Sheba MDC).
All donors provided written informed consent for the collection of
all samples and subsequent analysis.
Cell culture
3T3 cells were grown at 37uC in humidified incubator with 5%
CO2, in DMEM (high, 4.5 g/l glucose), 10% FCS (Gibco), 2 mM
l-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and
0.25 mg/ml Amphotericin B (all from Biological Industries, Beit
Haemek, Israel). To block 3T3 cell proliferation, cells at 70%
confluency were incubated with Mitomycin-c (4 mg/ml, Sigma) for
90 min. The cells were subsequently washed by PBS and cultured
in DMEM for additional 24 h before used as a feeder layer for the
human keratinocytes.
Primary culture of human keratinocytes
Keratinocytes isolation and culture were performed as
previously described [33–35]. Skin tissues were cut to 2–3 cm
2
pieces, washed twice in PBS and incubated overnight at 4uCi n
2 U/ml Dispase (Gibco). The epidermis was separated and
i n c u b a t e di nt r y p s i na t3 7 uC for 10 min, cells were collected by
centrifugation and seeded on the mitomycin c treated 3T3 cells at
the density of 10
7 cells/100 mm plate. The culture media used was
Green medium (Green et al [33–35]), composed of F-12 Nutrient
mixture with DMEM High glucose (1:3), 2 mM l-glutamine,
100 U/ml penicillin, 100 mg/ml streptomycin, 0.25 mg/ml Am-
photericin B, 0.05 mg/ml Gentamycin Sulphate (Biological Indus-
tries, Beit Haemek, Israel), 10% FCS (Gibco), 10 ng/ml Epidermal
Growth Factor, 10
210 M Cholera Toxin, 0.4 mg/ml Hydrocorti-
sone, 2 nM T3, 5 mg/ml Transferrin, 5 mg/ml Insulin, 0.18 mM
Adenine (all from Sigma). Within a week or two the keratinocytes
grow and filled the plate, displacing the 3T3 cells. Subsequently, the
cells were split once a week as the cells reached confluence but
before the cells started to undergo spontaneous stratification. Cells
detachment was performed by trypsin, and the cells were seeded
without the feeder layer at 10
6 cells/100 mm plate, for up to 6
passages.
Viral infection
For adenovirus infection, keratinocytes at passage 2–4 were
plated at 3610
6 cells/100 mm plates and infected with the
relevant recombinant adenovirus on the next day at 10–1000 moi
(multiplicity of infection). The following adenoviruses were used in
this study: Ad-CMV-PDX-1 (replication-deficient recombinant
adenovirus that encodes rat PDX-1 cDNA under the control of
the cytomegalovirus promoter,[36]); Ad-CMV-GFP (Clontech,
Mountain View, CA); Ad-CMV-b-gal (a gift from C.B. Newgard,
Duke, NC); Ad-RIP-GFP [18]; Ad-RIP-luciferase [36].
Luciferase assay
Keratinocytes were co-infected with Ad-RIP- luciferase
(200moi) and Ad-CMV-PDX-1 or Ad-CMV-b-gal as control
(both at 1000moi). Seven days later, lucifease activity was
measured using Lucifersase assay System (Promega) by LKB
1250 Luminometer (LKB, Finland). The results were normal-
ized to total cellular protein measured by the Bio-Rad Protein
Assay kit (Bio-Rad).
Letniviruses production and infection
The two component lentivirus system described by Russ et. al.
[37], was used to irreversibly label keratinocytes for KRT5
expression manifested by its promoter activity. Human keratino-
cytes at passage 2 were co-infected with the Reporter vector
CMV-loxP-DsRed2-loxP-eGFP (R/G) and a vector which carries
the expression of Cre-recombinase under the control of the KRT5
promoter (a gift from P.W. Zoltick [38]). R/G treatment resulted
in DsRed2 but not eGFP expression. The KRT5 promoter
activates Cre-recombinase expression only in KRT5 positive cells
which cleaves the ‘‘floxed’’ DsRed2, allowing the expression of
eGFP under the CMV promoter. Keratinocytes which are positive
to KRT5 and co-express both lentiviruses are expected to activate
eGFP and lose the original DsRed2 labeling [37]. Ten days
subsequent to lentivirus infection, keratinocytes were treated to
ectopically express pancreatic transcription factors, using recom-
binant adenoviruses.
RNA isolation, RT and RT-PCR reactions
Total RNA was isolated, cDNA was prepared and amplified
as described previously [12,18].Q u a n t i t a t i v er e a l - t i m eR T -
PCR was performed using ABI StepOnePlus sequence
Detection system (Applied Biosystems, CA, USA) as described
previously [18,20,39]. The primer sets used in this study are
listed in Methods S1.
Keratinocytes to Pancreas Transdifferentiation
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Keratinocytes were seeded on cover-slips and infected with
the indicated adenovirus on the next day. Seven days later cells
were fixed and stained as previously described [18,20,39]. The
antibodies used in this study were: anti mouse KRT5 (1:100),
anti human P63 (1:100) anti human KRT8/18 (1:200), anti
human Ki67 (1:150)(all from Abcam, Cambridge UK), anti
human C-peptide (1:200 Biodesign, Maine, USA), anti human
glucagon (1:200, Dako, Glostrup, Denmark), anti mouse
NKX6.1 (1:6000 a generous gift from C.B. Newgard, Duke
University), anti mouse NEUROD1 (1:00, Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), anti mouse NGN3 (1:50) anti
chick NKX2.2 (1:50) both from Developmental Studies
Hybridoma Bank, Iowa, USA), anti-CRE (1:1,000; Novagen),
anti-rabbit PDX-1, anti- goat PDX-1 (both 1:10000 a generous
gift from C.V. E. Wright). Anti-Secondary anti-rabbit IgG
Cyanine (cy2) conjugated antibody, anti-rabbit IgG indocarbo-
cyanine (cy3) conjugated antibody, anti-goat IgG Cyanine (cy2)
conjugated antibody, anti-goat IgG indocarbocyanine (cy3)
conjugated antibody, anti-mouse IgG Cyanine (cy2) conjugated
antibody, anti-mouse IgG Indodicarbocyanine (cy5) conjugated
antibody, anti-mouse IgG Aminomethylcoumarin (AMCA)
conjugated antibody and anti-mouse IgG indocarbocyanine
(cy3) conjugated antibody (all 1:250 from Jackson ImmunoResearch,
PA). Finally, the cells were stained with 49, 6-diamidino-2-
phenyl-indole (DAPI, Sigma). The slides were analyzed using a
fluorescent microscope (Provis, Olympus), or Laser Scanning
Confocal microscopy (Bio-Rad, LSM-1024).
C-peptide secretion
C-peptide secretion was measured by static incubations of
keratinocytes cells, 7 days after the initial exposure of the cells to
the adenovirus treatment as described [18,39]. The glucose
regulated insulin and c-peptide secretion were measured at 2
and 25 mM glucose or 2 Deoxy-D-glucose, at similar concentra-
tions. C-peptide secretion was detected by radioimmunoassay
using human C-peptide radioimmunoassay kit (Linco Research,
St. Charles, MO; ,4% cross-reactivity to human proinsulin/
insulin). The secretion was normalized to the total cellular protein
measured by a Bio-Rad protein assay kit.
Statistical Analyses
Statistical analyses were performed with a 2-sample Student t
test assuming unequal variances
Results
Characterization of primary human keratinocyte cultures
Monolayer cultures of human keratinocytes derived from both
neonates and adults were allowed to proliferate for up to 5–6
passages (Fig. 1, 25% Ki67 positive cells). Over 85% of the cells
expressed the keratin-5 protein (KRT5; Fig. 1c, d), but most were
negative for the KRT1/10 protein (immunofluorescence data not
shown). Approximately 10–15% of the cells expressed the KRT8/
18 cytokeratins, which are specifically expressed in simple
epithelium. Thus, these primary cells were in an early stage of
epidermal differentiation in culture (Fig. 1e) [40]. About 60% of
the cells in culture were positively stained for P63 nuclear factor,
which is a homolog to the tumor suppressor P53 and plays a
critical role in the development of stratified epithelia, like the
epidermis [41]. These keratinocytes were efficiently infected (70–
90%) in vitro with the adenoviral vector, Ad-CMV-GFP (1000 moi,
data not presented).
Expression of pancreatic transcription factors activate
pancreatic hormone gene expression in adult and
neonate human keratinocytes
Transcription factors that are instrumental in driving pancreatic
organogenesis in the embryo demonstrated a similar role in
reprogramming adult endoderm-derived cells to follow the
pancreatic lineage. Several transcription factors, including PDX-1
[12,19,22–24], NEUROD1 [42], or NGN3 [26] have exhibited
individual roles in liver cell transdifferentiation to the pancreatic
lineage. To determine whether these factors could induce a similar
developmental process in cells of developmentally unrelated
tissues, we tested them individually for activating pancreatic
hormone gene expression in human keratinocytes. Ectopic
expression of pancreatic transcription factors was mediated by
viral infection with non-integrating, recombinant adenoviruses,
Ad-CMV-PDX-1, Ad-CMV-NGN3, Ad-CMV-NEUROD1, Ad-CMV-
MAFA,o rAd-CMV-NKX6.1 (all at 1000 moi). Ectopic NKX6.1
expression could not activate pancreatic hormone gene transcrip-
tion in keratinocytes, consistent with its lack of individual effect on
liver cells [21]. Ectopic NGN3 expression activated insulin and
glucagon, but not somatostatin transcription. Both PDX-1 and
NEUROD1 ectopic expression activated the transcription of all
three pancreatic hormones. However, PDX-1 induced a higher
level of hormones gene expression than NEUROD1(Fig. 2a).
Therefore, we focused on the individual ability of PDX-1 to drive
Figure 1. Characterization of primary culture of human
keratinocytes in-vitro. Human keratinocytes proliferated efficiently
for up to 5–7 passages in culture. (a, b) Representative phase contrast
images show the morphology of keratinocytes at passages (a) 0, and (b)
3. Arrowheads (a) indicate cells of the 3T3 fibroblast feeder layer in
passage 0; original magnification 610. (c–f) Keratinocytes (passage 3)
were stained for keratinocyte markers: (c) KRT5, (d) P63, (e) KRT8/18,
and (f) for the proliferation marker, Ki67. Nuclei were stained with DAPI
(blue); original magnifications, 620.
doi:10.1371/journal.pone.0026298.g001
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lineage.
PDX-1 activates transcription of numerous pancreatic
markers in keratinocytes
Expression of PDX-1 in human keratinocytes caused the
transcription of numerous genes characteristic of the pancreatic
lineage and b-like-cells (Fig. 2), without affecting cell morphology
(Fig. 3a, c). This effect of PDX-1, but not control virus, was dose
dependent in both neonatal and mature human keratinocy-
tes (Fig. 2b, c). Due to their ready availability and higher
responsiveness, we performed further analyses in neonatal-derived
human keratinocytes. PDX-1 expression activated the expression
of genes involved in b-cell glucose sensing (GLUT-2, GK),
prohormone processing (PC1/3 and PC2), and secretion granule
assembly (SGNE1; Fig. 2d). These genes, characteristic of
endocrine cells, were silent in untreated or control treated
keratinocytes. The considerable pancreatic repertoire induced by
PDX-1 could partly be attributed to its marked activation of
numerous pancreatic-specific transcription factor genes (Fig. 2e, f),
including NGN3, ISL1, NEUROD1, NKX2.2, NKX6.1, MAFA,
PAX4, and the endogenous human PDX-1. Importantly, many of
the treated human keratinocytes exhibited co-localization of PDX-
1 and the induced transcription factors in the nucleus (Fig. 4); 51%
of PDX-1 positive cells were positive to NGN3; 41% were positive
to NKX2.2; 45% were positive to NKX6.1 and 46% were positive
to NEUROD1. Taken together these data suggest that PDX-1
induced a wide developmental alteration when ectopically
expressed in human keratinocytes.
The efficiency of PDX-1 induced keratinocytes
reprogramming along the endocrine pancreatic lineage
To examine the efficiency of reprogramming skin keratinocytes
to become insulin-producing cells, we determined the percentage
of PDX-1 treated keratinocytes that were capable of activating an
ectopically expressed insulin promoter.
Human keratinocytes were co-treated with either Ad-CMV-
PDX-1 or Ad-CMV-b-gal control recombinant adenoviruses (1000
moi) and Ad-RIP-GFP, which carries the GFP reporter gene
sequence under the control of the rat insulin promoter 1 [18].
Twenty five percent of cells were capable of activating the ectopic
pancreatic insulin promoter upon PDX-1 infection; no signal was
detected with control adenovirus infection (Fig. 3a–d). The PDX-1
dependent activation of the insulin promoter was further
Figure 2. Ectopic PDX-1 expression promoted pancreatic differentiation in human keratinocytes. (a) Human keratinocytes isolated from
neonatal foreskin were analyzed by quantitative RT-PCR to determine insulin (INS), glucagon (GCG), and somatostatin (SST) gene transcription levels
induced by adenoviral infections with transcription factor genes PDX-1, NGN3, NKX6.1,o rNEUROD1. The control virus carried only the b-gal gene
sequence. All vectors were infected at 1000 moi and cells were analyzed 7 days post infection. (b) Human keratinocytes isolated from neonatal
foreskin or adult skin grafts, (9–70 year-old donors) were infected with increasing concentrations of PDX-1 (10–1000 moi) or control (b-gal) adenovirus
constructs to determine INS gene transcription. (c) Adult keratinocytes were infected with increasing concentrations of PDX-1 (10–1000 moi) or
control (b-gal) adenovirus constructs to determine GCG and SST gene transcription levels. (d, e, f) Keratinocytes from neonatal foreskin were infected
with PDX-1 or control (b-gal) adenovirus constructs (both at 1000 moi) to determine transcription levels of genes encoding (d) pancreatic-specific
proteins, (e) pancreatic specific transcription factors, and (f) b-cell specific transcription factors. The results are normalized to b-actin gene
transcription within the same cDNA samples. The mean 6standard deviations are expressed as the signal strength relative to cells treated with the
control virus. All results represent n$8 samples tested in three independent experiments *P,0.01.
doi:10.1371/journal.pone.0026298.g002
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showed that the insulin promoter was significantly stimulated by
PDX-1 (Fig. 3e).
Ectopic insulin promoter activation provides an essential clue on
the reprogramming efficiency; however, it does not reflect changes
in the epigenetic status of the host cells, as the adenovirus reporter
gene (Ad-RIP-GFP or Ad-RIP- Luciferase) does not integrate into the
host genome. A more stringent indication for reprogramming
toward b-cell lineage can be obtained by analyzing endogenous
insulin gene expression (Fig. 2b) and hormone production (Fig. 5).
Indeed, 12.6168% of PDX-1 positive cells stained positive for the
endogenous insulin (C-peptide, detected with the anti-human C-
peptide antibody; Biodesign; Fig. 5b & c). Ectopic PDX-1
expression also activated glucagon production in human kerati-
nocytes (Fig. 5e & f). Co-localization of PDX-1 in glucagon
producing cells, may suggest these cells immature characteristics.
Taken together these data demonstrate the capacity of PDX-1 to
activate the pancreatic lineage in human keratinocytes at the
molecular and cellular levels. Although ectopic expression of
PDX-1 was detected in 70–90% of all cells in culture, the
activation of the pancreatic phenotype occurred only in scattered
keratinocytes, which as in liver may be prone to transdifferentia-
tion [18,20,22,39]. The nature or the characteristics of the
predisposed cells is not yet understood.
PDX-1 induced b-cell-like function in human skin
keratinocytes
The significant activation of numerous markers and transcrip-
tion factors characteristic of the endocrine pancreas together with
the generation of pancreatic hormones producing cells, motivated
us to determine whether PDX-1 also activated b-cell-like function
in the ectoderm-derived human keratinocytes.
The most critical demonstration of b-cell-like function is the
capacity to produce insulin, sense glucose, and accordingly,
secrete the processed hormone [43]. We incubated PDX-1
treated keratinocytes with low (2 mM) or high (25 mM) glucose
concentrations and analyzed C-peptide secretion into the media
as an indicator of processed insulin (human C-peptide RIA
(Linco, ,4% cross-reactivity to human proinsulin or insulin)). We
found that PDX-1 treated keratinocytes released the processed
hormone only upon exposure to high concentrations of glucose
(Fig. 5g). A non-metabolizable glucose analog, 2-deoxy-glucose
(2-DOG), served both as an indicator of osmolarity and a
functional control. We found that a similar concentration of 2-
DOG (25 mM) did not trigger C-peptide secretion (Fig. 5g). This
suggested that, like pancreatic b-cells, the reprogrammed
keratinocytes required glucose metabolism to trigger insulin
secretion; thus, glucose metabolism was coupled to the hormone
secretion process.
Figure 3. Nuclear localization of PDX-1 induced pancreatic transcription factor expression in human keratinocytes. Human
keratinocytes isolated from neonatal foreskin were analyzed 7 days subsequent to Ad-PDX-1 infection (ectopic PDX-1). Double Immunofluorescence
analyses showed co-localization of (i, ii, iii) NGN3 (red) and ectopic PDX-1 (green); (iv, v, vi) NEUROD1 (red) and ectopic PDX-1 (green); (vii, vii, ix)
NKX6.1 (green) and ectopic PDX-1 (red); and (x, xi, xii) NKX2.2 (red) and ectopic PDX-1 (green). In panels iii, vi, ix, and xii, the images were
superimposed to visualize co-localization (merged colors). Nuclei were stained with DAPI (blue). Original magnification620; arrows indicate double-
stained cells.
doi:10.1371/journal.pone.0026298.g003
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expression of early endodermal markers but not that of
other adult endodermal tissues, in human keratinocytes
During pancreas development in the embryo, early
endodermal markers expression exceeds that of PDX-1.
Surprisingly, in ectoderm-derived cells, PDX-1 activated the
expression of numerous early endodermal markers (Fig. 6a).
The expression of endodermal markers SOX17 and GATA4
was evident within 48 h while insulin expression was
maximally detected 5–7 days after PDX-1 treatment (data
not presented).
Despite the activation of the general endodermal markers,
neither pancreatic exocrine genes (Amylase), nor hepatic markers
(ADH1b and AFP; Fig. 6b) expression was induced in human
keratinocytes, suggesting the specificity of the PDX-1 induced
reprogramming process.
PDX-1 inhibits the expression of keratinocytes markers
but does not activate embryonic cell markers, in human
keratinocytes
Hepatic dedifferentiation has been suggested essential for the
activation of the alternate pancreatic repertoire [39]. Moreover,
PDX-1 has been suggested to play a dual role in liver to pancreas
reprogramming by both repressing the host repertoire of expressed
genes, while activating the alternate pancreatic repertoire. To
analyze whether PDX-1 plays a similar role in human keratino-
cytes, we analyzed its effect on typical keratinocytes markers
expression. Ad-PDX-1 but not control virus, repressed KRT5,
Figure 4. Ectopic PDX-1 expression activated the insulin promoter in human keratinocytes in-vitro. Human keratinocytes isolated from
neonatal foreskin were co-infected with either the control virus Ad-b-gal or Ad-PDX-1 (both at 1000 moi) and a reporter gene of either (a–d) Ad-RIP-
GFP (1000 moi,) or (e) Ad-RIP-Luciferase (100 moi,), for 7 days. (a, c) Representative phase contrast micrographs show cell morphology. (b, d) Green
fluorescent protein imaging of the same fields (a&b; c&d) presented in the phase contrast. (b) control cells did not express GFP; and (d) PDX-1
stimulated GFP expression in numerous cells. (e) Luciferase activity of the infected keratinocytes. The mean 6standard deviation is expressed in
relative luciferase units; data represents n$8 samples in three independent experiments.
doi:10.1371/journal.pone.0026298.g004
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expression (Fig. 6f&g). Along with the repression of keratinocytes
markers, PDX-1 repressed both p63 isoformes expression (TAp63
and DNp63; Fig. 6c). These isoforms endow the keratinocytes’
transcription factor, p63, a dual role in initiating the epithelial
stratification during development and maintaining proliferate
potential of basal keratinocytes in mature epidermis [41].
On the other hand, PDX-1 treatment slightly increased the
transcription of KRT-8/18, cytokeratin filament proteins that are
typically expressed in unstratified basal epithelial cells in skin
development [44]. Since KRT-8/18 is also expressed in
pancreatic epithelial cells, increases in KRT-8/18 expression
could reflect either a developmental regression of KRT5 positive
keratinocytes to an earlier developmental stage or a develop-
mental shift of KRT5 positive cells toward the endocrine
pancreatic lineage. The fact that PDX-1 repressed the expression
of keratinocyte-specific markers and transcription factor, like
KRT1, KRT10 and p63 which mark and control keratinocyte
stratification, suggested that PDX-1 may perturb normal
epidermal differentiation (Fig. 6c). Importantly, PDX-1 induced
keratinocytes markers repression was not associated with
increased cell proliferation (unaltered Ki67 staining) or with
increase in the pluripotent cells markers such as NANOG, OCT-
4 and SOX2 expression (Fig. 6h). Taken together these data
suggest that PDX-1 induced keratinocytes reprogramming along
the pancreatic lineage is associated with restricted developmental
regression but not with induced pluripotency.
Lineage tracing: PDX-1 activates the pancreatic lineage in
keratinocytes
Co-localization of insulin (C-peptide) and keratinocyte markers,
may suggest that insulin producing cells are indeed generated in
keratinocytes upon ectopic PDX-1expression. However, because
PDX-1 repressed keratinocyte marker expression (Fig. 6 c–g), we
irreversibly tagged keratinocytes for KRT5 expression prior to the
ectopic PDX-1 treatment. We used a lentivirus-based dual
expression system for tracing cell fate in vitro [37]. This genetic
manipulation allowed continuous tracking of keratinocytes’ fate
after the endogenous KRT5 expression vanished. Lentiviral
infection of the keratinocytes was performed at passage 2. The
reporter virus alone infected 47610.4% of cells (averaged over 3
cultures). Double lentivirus infections were successful in
22.8610.4% of cells, based on measurements of the constitutively
active CMV-CRE virus (Fig. S1). Expression of eGFP upon
DsRed2/eGFP reporter and KRT-5 Cre-recombinase treatment
was detected in 20.567.4% of cells (Fig. S1). The specificity of
KRT5 lineage tracing was exemplified by co staining for the Cre-
recombinase protein which was restricted only to KRT5 positive
cells (data not presented). Thus, the KRT5 promoter-CRE
lentiviral system specifically and irreversibly tagged KRT5-positive
cells.
Keratinocytes irreversibly labeled with KRT5 expression were
treated with Ad-CMV-PDX-1 and immunostained for co-expres-
sion of eGFP and C-peptide (Fig. 7b). Indeed, C-peptide positive
cells generated upon PDX-1 treatment, also expressed eGFP,
Figure 5. Ectopic PDX-1 expression induced insulin and glucagon expression and promoted glucose-regulated C-peptide secretion.
Double immunofluorescence of human keratinocytes isolated from neonatal foreskin treated with (a, d) control Ad-b-gal or (b–c, e–f) Ad-PDX-1
adenovirus for 7 days. Immunofluorescence analyses showed co-localized expression of (a–c) PDX-1(green) and insulin (red) and (d–f) PDX-1(red) and
glucagon (green). The nuclei were stained with DAPI (blue). (a–b, d–e). Original magnification620 (c, f); original magnification (confocal microscope)
690. (g) Human keratinocytes were infected with Ad-b-gal or Ad-PDX-1, both at 1000 moi, and analyzed for secretion of processed insulin into the
culture medium upon exposure to 2 and 25 mM glucose or 25 mM 2DOG. C-peptide in the medium was measured with a specific RIA kit (Linco
human c-peptide no crossreactivity with pro-insulin). Data represents n$7 samples in four independent experiments.
doi:10.1371/journal.pone.0026298.g005
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keratinocytes that werepositive for KRT5 expression prior to PDX-
1 induced reprogramming. The relatively low efficiency of lenti-
virus infection (20.567.4% of KRT
+ cells), cannot rule out the
possibilitythatadditionalcellsintheculturecouldgive risetoinsulin
producing cells. Nonetheless, C-peptide and eGFP co-expression,
unequivocally suggest that PDX-1 was capable of activating insulin
production in ectoderm-derived human keratinocytes.
Discussion
The present study demonstrated for the first time the capacity to
directly activate the endocrine pancreatic lineage and function in
ectoderm derived human keratinocytes. Our data suggested that
transcription factors that control pancreas organogenesis such as
PDX-1 could activate the pancreatic lineage and function in adult
cells of developmentally unrelated tissue in a process which crosses
the boundaries of distinct developmental germ layers. This
transdifferentiation process is associated with host cells dediffer-
entiation but not with increased cells proliferation or induction of
embryonic markers expression.
PDX-1 treated keratinocytes acquired ‘endocrine-like’ charac-
teristics associated with specific activation of proinsulin processing
enzymes, granule assembly markers, and a glucose sensing ability
associated with GLUT-2 and Glucokinase (Hexokinase-4) gene
expression. None of these properties were detected in control
treated keratinocytes (Fig. 2d). The reprogrammed keratinocytes
acquired b-cell like functions, including insulin production,
processing, and secretion in response to elevated glucose
concentration (Fig. 5g). Moreover, like in pancreatic b-cells and
in reprogrammed liver cells [18,45], insulin secretion could only
be stimulated by glucose, and similar concentrations of the non-
metabolizable glucose analog, 2-DOG had no effect on insulin
secretion from reprogrammed human keratinocytes. This indi-
Figure 6. Ectopic PDX-1 activated early endoderm but not hepatic or pancreatic acinar markers, while repressing the expression of
keratinocyte-specific markers. Human keratinocytes isolated from neonatal foreskin were infected with Ad-b-gal or Ad-PDX-1 (both at 1000 moi)
for 7 days. Quantitative real time RT-PCR analyses indicated the relative transcription levels of (a) early endoderm-specific markers, (b) hepatic and
pancreatic acinar markers, (c) keratinocyte markers or (h) embryonic stem cell markers. The results were normalized to the level of b-actin gene
transcription within the same cDNA sample. The mean 6standard deviations of Ad-PDX-1 treated cells are expressed relative to the mean levels
observed in Ad-b-gal treated cells. n$6 from 3 different cultures. *P,0.01, **P,0.05 (h) cDNA extracted from human embryonic cells was used as
positive control. (d–g) Cells treated with either (d, f) Ad-b-gal or (e, g) Ad-PDX-1 were fixed and co-stained for (d, e) KRT5 (green) and PDX-1 (red) or for
(f, g) GFAP (green) and PDX-1 (red). The nuclei were stained with DAPI; magnification: d–g 630.
doi:10.1371/journal.pone.0026298.g006
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compartments and the glucose-sensing apparatus in PDX-1
treated keratinocytes (Fig. 5g).
The reprogramming of human keratinocytes to produce insulin
occurred in a relatively short period of time and was relatively
efficient,whencomparedtoreprogrammingintopluripotency.PDX-
1 activated insulin production in 12.6168% of cells, 5 to 7 days
subsequent to Ad-PDX-1 administration. In contrast, reprogram-
ming adult cells into pluripotent cells (iPS) typically takes .20 days
[6,46] with an efficiency of 0.05–0.1%; or 3.3% in clonal cells [5,6].
Reprogramming ectoderm-derived cells to become endocrine
pancreatic-like cells occurred without integration of the develop-
mental factor into the host genome [47]. Ectopic rat PDX-1
delivered by recombinant adenoviruses, activated endogenous
human PDX-1 and numerous additional pancreatic transcription
factors that are typically silent in this ectoderm derived tissue, and
which may have collectively activated the downstream a and b cell
specific, adult, functional markers (Figs. 2e–f & 3). The activation of
endogenous PDX-1 may suggest that despite the episomal nature of
the ectopic PDX-1 gene, the induced reprogramming process may
be irreversible, although this should be further directly analyzed.
Reprogramming induction in the absence of integration of foreign
genetic information has important safety advantage [48–51].
Our data suggested that PDX-1 plays a dual role in re-
programming keratinocytes to become b-like-cells, as it both
repressed host repertoire of gene expression, while activating the
pancreatic lineage protein expression in keratinocytes (Fig. 5 & 6c–
g). Since it seems unlikely that PDX-1 could directly repress
expression of multiple genes in the keratinocytes through a direct
effect, it could potentially repress a keratinocytes specific transcrip-
tion factor, which may in turn affect multiple keratinocytes markers
expression. Indeed, a similar dual role was described in PDX-1
induced reprogramming of liver along the pancreatic lineage [39].
Hepatic dedifferentiation was obligatory for the PDX-1 induced
activation of the pancreatic lineage in liver, and was associated
with PDX-1 induced CEBPb repression [39]. When ectopically
expressed in keratinocytes, PDX-1 repressed p63 expression which
was suggested essential for epithelial stratification and normal skin
development [41]. However, the direct association between
keratinocytes dedifferentiation and p63 repression should be further
directly analyzed. PDX-1 induced keratinocytes dedifferentiation
was not associated by increased cells proliferation or by the
activation of early embryonic stem cells markers such as OCT-4,
NANOG and SOX-2 (Fig. 6h). This may suggest that restricted
developmental regression rather than complete induction of a
pluripotent state is sufficient for the activation of the alternate
pancreatic repertoire, by ectopic expression of transcription factors
of committed cell lineages.
PDX-1 activated SOX17 and GATA-4 expression in keratino-
cytes (Fig. 6a). The activation of these endodermal markers was
intriguing because in pancreas organogenesis in the embryo SOX
17 expression precedes that of PDX-1 [52]. The potential role of
endodermal markers expression which is associated with the
activation of the pancreatic lineage in PDX-1 treated keratinocytes
should be further analyzed in future studies. On the other hand,
SOX 17 expression may prevent further dedifferentiation into
pluripotency as suggested by Niakan et al [53]. Despite its capacity
to activate early endodermal markers, PDX-1 specifically activated
endocrine pancreatic markers and not markers of other adult
endodermal tissues, such as liver and exocrine pancreas (Fig. 6b).
The advantage of the transdifferentiation process described here
is that it is relatively fast and is neither mediated by integration of
foreign genetic information nor episodes of uncontrolled cell
proliferation. Moreover, the generated cells are equipped by the
desired characteristics and function, to be potentially used in cell
therapy approaches. However, the total number of reprogrammed
cells is restricted since most of the generated cells are post mitotic.
To overcome the limited number of committed cells generated,
the reprogramming efficiency should be further increased and the
transdifferentiation process should be initiated in an abundant
source of proliferating cells, which can be readily propagated prior
to reprogramming induction.
In summary, transdifferentiation of ectoderm derived kera-
tinocytes along the endodermal pancreatic lineage and function
serves as a proof of concept to suggest that the transcription factors
induced reprogramming is wider and more general developmental
process than initially considered. The present study has enlarged
the arsenal of potential cell sources suitable for regenerative
medicine approaches, and future studies may utilize the most
accessible and efficiently proliferating cells to be used as the
desired source of tissue for cell therapy protocols.
Supporting Information
Figure S1 Lineage tracing for KRT5 positive cells
(keratinocytes). HaCaT cells (human keratinocytes cell line)
were co-infected with the reporter vector (R/G) and either the
constitutively active CMV-CRE vector (a–e, control) or the
KRT5-CRE vector (f–j; keratinocyte-specific promoter activity).
Seventy two hours (72 h) post infection, the cells express DsRed2
and/or eGFP. (a, f) Schematic presentation of the R/G reporter
and Cre lentiviral vectors; (b, g) Phase-contrast images; (c, h)
DsRed2 protein expression shows that many cells infected by the
DsRed2/eGFP reporter alone or infected by both lentiviruses but,
could not activate Cre; (d, i) eGFP protein expression shows the
Figure 7. C-peptide positive cells arose from keratinocytes
(KRT5 positive cells). Lineage tracing analyses were performed with
dual Cre-Lox lentiviral infections. (a) Schematic representation of the
Lox (upper) and Cre (lower) lentiviral vectors. Only cells that expressed
KRT5 could activate Cre expression; then, Cre would excise the DsRed2
gene between the Lox sites and remove a stop codon preceding the
eGFP gene, which is subsequently controlled by the CMV promoter. (b)
Ten days after the dual lentiviral infection, cells were treated with Ad-
PDX-1 for 7 days. Fixed cells were stained with three immunofluorescent
antibodies and examined with a confocal microscope to detect
keratinocytes that processed insulin. (i, ii, iii) GFP (green) identifies the
cell as a keratinocyte, PDX-1(blue) shows successful ectopic protein
expression, and c-peptide (turquoise) shows processed insulin produc-
tion. (iv) Superimposed images show that all three proteins are
expressed within the same cell. Original magnification 690.
doi:10.1371/journal.pone.0026298.g007
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PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e26298cells that were able to activate Cre. (e, j) Superimposed images
show merged colors (yellow) where proteins are co-localized. Co-
labeling with eGFP and DsRed2 likely reflects the activity of the
Cre recombinase and the relatively long half-life of the DsRed2
protein (t1/2=4.5 days), such that the DsRed2 protein can be
detected even 1–2 weeks after the DsRed2 gene is no longer
expressed [34]. Original magnification 620.
(TIF)
Methods S1 Quantitative real-time RT-PCR primers
list. The primer sets used in this study are listed. Annealing
temperate of all primers is 60uc.
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